A detailed history of Xtx Topco LTD transactions in Axogen, Inc. stock. As of the latest transaction made, Xtx Topco LTD holds 17,306 shares of AXGN stock, worth $346,293. This represents 0.03% of its overall portfolio holdings.

Number of Shares
17,306
Holding current value
$346,293
% of portfolio
0.03%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025

BUY
$12.47 - $17.19 $215,805 - $297,490
17,306 New
17,306 $285,000
Q1 2024

May 13, 2024

SELL
$6.63 - $10.69 $32,666 - $52,669
-4,927 Reduced 27.34%
13,093 $105,000
Q4 2023

Feb 13, 2024

SELL
$3.61 - $7.76 $65,730 - $141,294
-18,208 Reduced 50.26%
18,020 $123,000
Q3 2023

Nov 13, 2023

BUY
$4.68 - $9.26 $5,934 - $11,741
1,268 Added 3.63%
36,228 $181,000
Q2 2023

Aug 14, 2023

BUY
$8.5 - $10.38 $297,160 - $362,884
34,960 New
34,960 $319,000

Others Institutions Holding AXGN

About Axogen, Inc.


  • Ticker AXGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 42,283,700
  • Market Cap $846M
  • Description
  • AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...
More about AXGN
Track This Portfolio

Track Xtx Topco LTD Portfolio

Follow Xtx Topco LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.